Анализ литературы орофарингеальный кандидоз

1. Aljaffary M. et al. Effects of Nystatin oral rinse on oral Candida species and Streptococcus mutans among healthy adults //Clinical Oral Investigations. – 2023. – Т. 27. – №. 7. – С. 3557-3568.
2. Alkhars N. et al. Antifungal Susceptibility of Oral Candida Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin //Journal of Fungi. – 2023. – Т. 9. – №. 5. – С. 580.
3. Anwar S. K. et al. Curcumin nanoparticles: The topical antimycotic suspension treating oral candidiasis //Odontology. – 2023. – Т. 111. – №. 2. – С. 350-359.
4. Bertolini M, Vazquez-Munoz R, Archambault L, Shah S, Souza JGS, Costa RC, Thompson A, Zhou Y, Sobue T, Dongari-Bagtzoglou A. 2021. Mucosal bacteria modulate Candida albicans virulence in oropharyngeal candidiasis. mBio 12:e0193721.
5. Bohner F, Papp C, Gácser A. The effect of antifungal resistance development on the virulence of Candida species. FEMS Yeast Research. 2022; 22: foac019.
6. Bu, Q.-R., Bao, M.-Y., Yang, Y., Wang, T.-M. & Wang, C.-Z. Targeting virulence factors of Candida albicans with natural products. Foods 11, 2951 (2022).
7. Cannon, R.D. Oral Fungal Infections: Past, Present, and Future. Front. Oral Health 2022, 3, 838639.
8. Clavel T, Desmarchelier C, Haller D, Gérard P, Rohn S, Lepage P, Daniel H. 2014. Intestinal microbiota in metabolic diseases. Gut Microbes 5:544–551.
9. Contaldo M. Use of Probiotics for Oral Candidiasis: State of the Art and Perspective. A Further Step Toward Personalized Medicine? //Frontiers in Bioscience-Elite. – 2023. – Т. 15. – №. 1. – С. 6.
10. Contaldo, M.; Di Stasio, D.; Romano, A.; Fiori, F.; Della Vella, F.; Rupe, C.; Lajolo, C.; Petruzzi, M.; Serpico, R.; Lucchese, A. Oral candidiasis and novel therapeutic strategies: Antifungals, phytotherapy, probiotics, and photodynamic therapy. Curr. Drug Deliv. 2023, 20, 441–456.
11. Cravener, M. V. et al. Reinforcement amid genetic diversity in the Candida albicans biofilm regulatory network. PLoS Pathog. 19, e1011109 (2023).
12. di Spirito, F.; Caggiano, M.; di Palo, M.P.; Contaldo, M.; D’Ambrosio, F.; Martina, S.; Amato, A. Oral Lesions in Pediatric Subjects: SARS-CoV-2 Infection and COVID-19 Vaccination. Appl. Sci. 2022, 12, 8995.
13. Dohlman, A. B. et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell 185, 3807–3822.e3812 (2022).
14. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. 2009. Characterization of mucosal Candida albicans biofilms. PLoS One 4:e7967.
15. Evangelista AJ, Ferreira TL. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in the diagnosis of microorganisms. Future Microbiology. 2022; 17: 1409–1419.
16. Fisher, M. C. & Denning, D. W. The WHO fungal priority pathogens list as a game-changer. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-023-00861-x (2023).
17. Fleitas Martínez, O., Cardoso, M. H., Ribeiro, S. M. & Franco, O. L. Recent advances in anti-virulence therapeutic strategies with a focus on dismantling bacterial membrane microdomains, toxin neutralization, quorum-sensing interference and biofilm inhibition. Front. Cell. Infect. Microbiol. 9, 74 (2019).
18. Giacobbe DR, Maraolo AE, Simeon V, Magnè F, Pace MC, Gentile I, et al. Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression. Mycoses. 2020; 63: 334–342.
19. Hajifathali S. et al. Investigation of the antifungal effects of curcumin against nystatin-resistant Candida albicans //Dental Research Journal. – 2023. – Т. 20. – №. 1. – С. 50.
20. Hu Q. et al. Efficacy of photodynamic therapy in the treatment of oral candidiasis: a systematic review and meta-analysis //BMC Oral Health. – 2023. – Т. 23. – №. 1. – С. 802.
21. Ivanov, M., Ćirić, A. & Stojković, D. Emerging Antifungal Targets and Strategies. Int. J. Mol. Sci. 23, 2756 (2022).
22. Jerônimo, L.S.; Esteves Lima, R.P.; Suzuki, T.Y.U.; Discacciati, J.A.C.; Bhering, C.L.B. Oral Candidiasis and COVID-19 in Users of Removable Dentures: Is Special Oral Care Needed? Gerontology 2022, 68, 80–85.
23. Khaled J. M. et al. Distribution of Candida infections in patients and evaluation of the synergic interactions of some drugs against emerging fluconazole-and caspofungin-resistant C. auris //Journal of King Saud University-Science. – 2023. – Т. 35. – №. 4. – С. 102617.
24. Lachat, J. et al. Trans-cellular tunnels induced by the fungal pathogen Candida albicans facilitate invasion through successive epithelial cells without host damage. Nat. Commun. 13, 3781 (2022).
25. Lertsuphotvanit N. et al. Clotrimazole-loaded borneol-based in situ forming gel as oral sprays for oropharyngeal candidiasis therapy //Gels. – 2023. – Т. 9. – №. 5. – С. 412.
26. Macikowska K, Paruzel-Pliskowska A, Curlej-Wądrzyk A, Kałuża P, Pytko-Polończyk J. The condition of the oral cavity in patients receiving chronic steroid therapy - practical remarks. Polski Merkuriusz Lekarski. 2021; 49: 382–384.
27. Manikandan, S.; Vinesh, E.; Selvi, D.T.; Kannan, R.K.; Jayakumar, A.; Dinakaran, J. Prevalence of Candida among denture wearers and nondenture wearers. J. Pharm. Bioallied Sci. 2022, 14, S702–S705.
28. Mundula T, Ricci F, Barbetta B, Baccini M, Amedei A. Effect of Probiotics on Oral Candidiasis: A Systematic Review and Meta-Analysis. Nutrients. 2019; 11: 2449.
29. Nambiar, M.; Varma, S.R.; Jaber, M.; Sreelatha, S.V.; Thomas, B.; Nair, A.S. Mycotic Infections—Mucormycosis and Oral Candidiasis Associated with Covid-19: A Significant and Challenging Association. J. Oral. Microbiol. 2021,
30. Ninane, J.; Multicentre Study Group. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13, 330–337.
31. Patel M. Oral Cavity and Candida albicans: Colonisation to the Development of Infection. Pathogens. 2022; 11: 335.
32. Pisano, M.; Sangiovanni, G.; D\’Ambrosio, F.; Romano, A.; Di Spirito, F. Oral Care in a Patient with Long Arm Deletion Syndrome of Chromosome 18: A Narrative Review and Case Presentation. Am. J. Case Rep. 2022, 23, e936142.
33. Proctor, D. M., Drummond, R. A., Lionakis, M. S. & Segre, J. A. One population, multiple lifestyles: commensalism and pathogenesis in the human mycobiome. Cell Host Microbe 31, 539–553 (2023).
34. Ratemo SN, Denning DW. Burden of fungal infections in Kenya. Mycol. 2023;14:142–54.
35. Saftien, A., Puschhof, J. & Elinav, E. Fungi and cancer. Gut 72, 1410–1425 (2023).
36. Santonocito S, Giudice A, Polizzi A, Troiano G, Merlo EM, Sclafani R, Grosso G, Isola G. 2022. A cross-talk between diet and the oral microbiome: balance of nutrition on inflammation and immune system’s response during periodontitis. Nutrients 14:2426.
37. Setoodeh, A.; Panjeh-Shahi, S.; Bahmani, F.; Vand-Rajabpour, F.; Jalilian, N.; Sayarifard, F.; Abbasi, F.; Sayarifard, A.; Rostami, P.; Parvaneh, N.; et al. Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: Report of two novel AIRE gene pathogenic variants. Orphanet J. Rare Dis. 2022, 17, 1–9.
38. Solis NV, Filler SG. 2012. Mouse model of oropharyngeal candidiasis. Nat Protoc 7:637–642.
39. Sultan, A. S., Theofilou, V. I., Alfaifi, A., Montelongo-Jauregui, D. & Jabra-Rizk, M.-A. Is Candida albicans an opportunistic oncogenic pathogen? PLoS Pathog. 18, e1010413 (2022).
40. Syed S, Sadaf J, Ameeduzzafar Z, May N, Sultan A. Formulation of miconazole- loaded chitosan-carbopol vesicular gel: optimization to in vitro characterization, irritation, and antifungal assessment. Pharmaceutics. 2023;15:581.
41. Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H, Abe S. 2003. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol 47:321–326.
42. Thompson G. R. et al. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial //The Lancet. – 2023. – Т. 401. – №. 10370. – С. 49-59.
43. Tsuchiya M, Niijima-Yaoita F, Yoneda H, Chiba K, Tsuchiya S, Hagiwara Y, Sasaki K, Sugawara S, Endo Y, Tan-No K, Watanabe M. 2014. Long-term feeding on powdered food causes hyperglycemia and signs of systemic illness in mice. Life Sci 103:8–14.
44. Vazquez-Munoz R, Thompson A, Sobue T, Dongari-Bagtzoglou A. 2023. A prebiotic diet modulates the oral microbiome composition and results in the attenuation of oropharyngeal candidiasis in mice. Microbiol Spectr 11:e0173423.
45. Yan L, Combs GF, DeMars LC, Johnson LAK. 2011. Effects of the physical form of the diet on food intake, growth, and body composition changes in mice. J Am Assoc Lab Anim Sci 50:488–494.
46. Zahra A, Mohamed A, Javid A, Negar S. In vivo study of antifungal effects of-low-molecular weight chitosan against candida albicans. J Oral Sci. 2017;59:425–30.